Catalog

Hypertrophic Cardiomyopathy State-of-the-Art: Comprehensive Echocardiographic Evaluation [Part 1]
Online
Added:04/13/2021 3:43 PM

The webinar is the first in a series of webinars supported by an unrestricted educational grant from Bristol Myers Squibb. The goal of the HCM webinar (part 1) is to understand the utility of echocardiography in the diagnosis and prognosis of HCM. In addition, the aim of the webinar is to review when the sonographer or echo reviewer should suspect HCM and what elements of the exam are most important in echo reporting.
Moderator: Allison Hays, MD, FASE
Speakers: Theodore Abraham, MD, FASE; Carolyn Ho, MD; and John Symanski, MD, FASE
Originally Recorded: April 6, 2021 | 12:00 - 1:00 PM ET
CME/MOC Information: 1.0 AMA PRA Category 1 CreditsTM
Activity Expiration Date: April 06, 2024 - CME/MOC must be claimed by this date
Learning Objectives:
• To describe the utility of echocardiography in the diagnosis and prognosis of HCM (quantifying LVOT gradients, MR and LVEF)
• To review when the sonographer/echo reviewer should suspect HCM and what elements of the exam are most important in echo reporting
• To understand of the different patterns of HCM (such as apical variant) and when contrast should be used
• To identify pitfalls in gradient assessment (emphasis on dynamic nature of gradients, distinguishing LVOT from mid-cavity, or apical, and sub-valvular membranes). To distinguish between other conditions in which outflow obstruction may be encountered
• To understand the indications for stress testing in HCM patients, how to perform and interpret stress echocardiography for HCM
• Brief overview of medical treatment of HCM--Understand how echo can be used to monitor HCM patient's response to therapy over time
This activity is FREE for ASE Members and Nonmembers.
PLEASE NOTE: Users who attended the live version of this webinar cannot also claim CME credit for the On-Demand Version. CME credit can only be claimed one time.
Credits awarded per Session. See individual Sessions for further details.
Credits awarded
Type
Name
Sub type
Value
Certificate awarded
$0.00
Already successfully completed: re-enrollment available!
Secure Transaction

Recently Added Items

    There's nothing to show just yet.

About this item

The webinar is the first in a series of webinars supported by an unrestricted educational grant from Bristol Myers Squibb. The goal of the HCM webinar (part 1) is to understand the utility of echocardiography in the diagnosis and prognosis of HCM. In addition, the aim of the webinar is to review when the sonographer or echo reviewer should suspect HCM and what elements of the exam are most important in echo reporting.

Moderator: Allison Hays, MD, FASE

Speakers: Theodore Abraham, MD, FASE; Carolyn Ho, MD; and John Symanski, MD, FASE

Originally Recorded:  April 6, 2021 | 12:00 - 1:00 PM ET

CME/MOC Information:  1.0 AMA PRA Category 1 CreditsTM

Activity Expiration Date: April 06, 2024 - CME/MOC must be claimed by this date

Learning Objectives:

• To describe the utility of echocardiography in the diagnosis and prognosis of HCM (quantifying LVOT gradients, MR and LVEF)

• To review when the sonographer/echo reviewer should suspect HCM and what elements of the exam are most important in echo reporting

• To understand of the different patterns of HCM (such as apical variant) and when contrast should be used

• To identify pitfalls in gradient assessment (emphasis on dynamic nature of gradients, distinguishing LVOT from mid-cavity, or apical, and sub-valvular membranes). To distinguish between other conditions in which outflow obstruction may be encountered

• To understand the indications for stress testing in HCM patients, how to perform and interpret stress echocardiography for HCM

• Brief overview of medical treatment of HCM--Understand how echo can be used to monitor HCM patient's response to therapy over time

This activity is FREE for ASE Members and Nonmembers. 

PLEASE NOTE: Users who attended the live version of this webinar cannot also claim CME credit for the On-Demand Version. CME credit can only be claimed one time. 

Course/Activity Information

Accreditation Statement:

The American Society of Echocardiography is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American Society of Echocardiography designates this activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program, and the American Board of Pediatrics (ABP) MOC program. It is ASE’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM and ABP MOC points.   Physicians will earn MOC points equivalent to the amount of CME credits claimed for the activity.

ARDMS and CCI recognize ASE’s certificates and have agreed to honor the CME credit hours toward their registry requirements for sonographers.

Disclosures: 

According to ACCME policy, ASE implemented mechanisms to resolve all conflicts of interest prior to the planning and implementation of this activity.

While a monetary or professional affiliation with an ineligible company does not necessarily influence a speaker’s presentation, the Standards for Integrity and Independence in Accredited Continuing Education and policies of the ACCME require that all financial relationships with ineligible companies* be identified and mitigated prior to engaging in an accredited CE activity. In accordance with these policies, ASE actively identified relevant financial relationships between faculty in control of this accredited CE activity and ineligible companies and implemented mitigation strategies to eliminate any potential influence from persons or organizations that may have an incentive to insert commercial bias in this activity. (*Companies that are ineligible to be accredited in the ACCME System (“ineligible companies”) are those whose primary business is producing, marketing, selling, reselling, or distributing healthcare products used by or on patients.)

The following moderators/speakers reported no actual or potential conflicts of interest in relation to this activity:

  • Allison Hays, MD, FASE
  • Theodore Abraham, MD, FASE

The following moderators/speakers reported relationships with one or more commercial interests:

  • John D. Symanski, MD, FASE; MyoKardia - Bristol Myers Squibb (Research Grant), (Advisory Board); Cytokinetics (Research Grant); Imbria Pharmaceuticals (Research Grant)
  • Carolyn Ho, MD; MyoKardia (Consultant, Advisor); Tenaya (Consultant; Advisor)

The following CME reviewers and ASE Staff reported no actual or potential conflicts of interest in relation to this document: 

  • Kathryn Lyons, ASE Healthcare Education Manager
  • Rita France, RDCS, RDMS, RT, FASE
  • Renee Bullock-Palmer, MD, FASE

Other information

  • Training Hours: 1.00
  • Additional Charges May Apply

    Ratings and reviews

    Close
    Shopping Cart
    Total:  Close

    Loading Shopping Cart Items...